AU2083788A - Virus proteins having reduced o-linked glycosylation - Google Patents

Virus proteins having reduced o-linked glycosylation

Info

Publication number
AU2083788A
AU2083788A AU20837/88A AU2083788A AU2083788A AU 2083788 A AU2083788 A AU 2083788A AU 20837/88 A AU20837/88 A AU 20837/88A AU 2083788 A AU2083788 A AU 2083788A AU 2083788 A AU2083788 A AU 2083788A
Authority
AU
Australia
Prior art keywords
reduced
linked glycosylation
virus proteins
virus
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20837/88A
Inventor
Leonard E. Post
Darrell R. Thomsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of AU2083788A publication Critical patent/AU2083788A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU20837/88A 1987-06-30 1988-06-17 Virus proteins having reduced o-linked glycosylation Abandoned AU2083788A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6821187A 1987-06-30 1987-06-30
US068211 1987-06-30

Publications (1)

Publication Number Publication Date
AU2083788A true AU2083788A (en) 1989-01-30

Family

ID=22081120

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20837/88A Abandoned AU2083788A (en) 1987-06-30 1988-06-17 Virus proteins having reduced o-linked glycosylation

Country Status (5)

Country Link
EP (1) EP0364492A1 (en)
JP (1) JPH02504103A (en)
KR (1) KR890701745A (en)
AU (1) AU2083788A (en)
WO (1) WO1989000196A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU616211B2 (en) * 1987-03-09 1991-10-24 Upjohn Company, The Transgenic animal cells resistant to viral infection
AU625328B2 (en) * 1989-06-27 1992-07-09 Smithkline Biologicals Recombinant varicella-zoster glycoproteins and their derivatives
AU626867B2 (en) * 1988-05-31 1992-08-13 Centre National De La Recherche Scientifique (Cnrs) Modified baculovirus, method for preparing it and its use as an expression vector of genes

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298239A (en) * 1991-10-07 1994-03-29 The Research Foundation Of State University Of New York Mutations rendering platelet glycoprotein IB α less reactive
US5317097A (en) * 1991-10-07 1994-05-31 The Research Foundation Of State University Of New York Mutations in the gene encoding the α chain on platelet glycoprotein IB

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127839B1 (en) * 1983-05-27 1992-07-15 THE TEXAS A&M UNIVERSITY SYSTEM Method for producing a recombinant baculovirus expression vector
US4877737A (en) * 1985-09-06 1989-10-31 Prutech Research And Development Partnership Attenuated pseudorabies virus which has a deletion in at least a portion of a repeat sequence and vaccine containing same
WO1987003206A1 (en) * 1985-11-25 1987-06-04 Quash Gerard A Modified viral glycoproteins, diagnostic and therapeutic uses therefore

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU616211B2 (en) * 1987-03-09 1991-10-24 Upjohn Company, The Transgenic animal cells resistant to viral infection
AU626867B2 (en) * 1988-05-31 1992-08-13 Centre National De La Recherche Scientifique (Cnrs) Modified baculovirus, method for preparing it and its use as an expression vector of genes
AU625328B2 (en) * 1989-06-27 1992-07-09 Smithkline Biologicals Recombinant varicella-zoster glycoproteins and their derivatives

Also Published As

Publication number Publication date
KR890701745A (en) 1989-12-21
EP0364492A1 (en) 1990-04-25
JPH02504103A (en) 1990-11-29
WO1989000196A1 (en) 1989-01-12

Similar Documents

Publication Publication Date Title
AU1628895A (en) Recombinant virus
AU2618088A (en) Fowlpox virus promoters
AU7831787A (en) Improved recombinant expression
AU7486887A (en) Novel procoagulant proteins
AU2204688A (en) Improved system
AU1926288A (en) Tetrahydrocarbaxole 1-alkanoic acids
AU2179788A (en) Combine harvester
AU2414288A (en) Polypeptide compounds
PH25327A (en) Binfunctional proteins
AU577288B2 (en) Polypeptides having interferon activity
AU6734587A (en) Inventory control system
AU2167888A (en) Substituted 2-phenyl-4-quinolinecarboxylic acids
AU1117288A (en) Tail bridge
AU575725B2 (en) Improved protein hydrolysate
AU1180088A (en) Protein extracts
AU8305687A (en) Glycosylated glycopeptides
AU5759190A (en) Protein hydrolysis
AU4927390A (en) Fusion proteins
AU4280985A (en) Dihydropyridine preparations
AU2066188A (en) Human reg protein
AU3804589A (en) Novel proteins
AU2083788A (en) Virus proteins having reduced o-linked glycosylation
AU5559786A (en) Recombinant human rennin
AU7993087A (en) Protein purification
AU7492087A (en) Newcastle disease virus protein